2348 On Other Exchanges
Symbol
Exchange
2348 is not on other exchanges.

Executive Profile*

Kehan Xu

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

43--

Background*

Mr. Kehan Xu served as a Strategic Adviser of Dawnrays Pharmaceutical Holdings Ltd until October 16, 2015. Mr. Xu served as the Chief Financial Officer and Finance Director of Dawnrays Pharmaceutical Holdings Ltd. from September 2004 to March 18, 2007 and also served as its Executive Director from March 17, 2004 to March 18, 2007. Mr. Xu served as a Strategic Adviser to the Chairman and Chief Investment Officer of Dawnrays Pharmaceutical Holdings Ltd until March 18, ...

Read Full Background

Corporate Headquarters*

CNT Tower
Wanchai, -- --

Hong Kong

Phone: 852 2111 9708
Fax: 852 2111 9870

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MBA
University of Miami
Doctorate
The Hong Kong Polytechnic University
PhD
Lowry Mays School of Business at Texas A&M University

Other Affiliations*

There is no Company Affiliations data available.

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact DAWNRAYS PHARMACEUTICAL HOLD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.